Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Martin Ton

Pain Medicine Virginia Beach, VA Medical Doctor

NPI 1316966427 CMS profile 241232

1080 First Colonial Rd Ste 201, Virginia Beach, VA 23454

Open in the dashboard

General payments

$2,129

37 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Martin Ton of Virginia Beach, VA is reported in the CMS Open Payments database as having received $2,129 across 37 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 47th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $72 2
2024 General $72 3
2023 General $44 1
2022 General $56 3
2021 General $225 5
2020 General $539 9
2019 General $1,120 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Martin Ton
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Martin Ton were reported at $72. Among 757 Pain Medicine profiles paid that year, the median was $470 and the middle half received between $146 and $1,462.

Show as a table
Year Martin Ton Pain Medicine median Middle half National median
2019 $1,120 $506 $144–$1,566 $163
2020 $539 $315 $96–$934 $114
2021 $225 $452 $134–$1,237 $132
2022 $56 $475 $124–$1,407 $149
2023 $44 $480 $136–$1,384 $160
2024 $72 $521 $164–$1,511 $164
2025 $72 $470 $146–$1,462 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $1,778 20 payments
  2. Pfizer Inc. $94 7 payments
  3. Avanos Medical $86 4 payments
  4. Heron Therapeutics, Inc. $69 1 payment
  5. Abbott Laboratories $42 2 payments
  6. SI-BONE, Inc. $31 2 payments
  7. Nevro Corp. $28 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,552 35 payments
  2. Travel and Lodging $577 2 payments
Products named General payments · program years 2019–2025
  1. SPECTRA WAVEWRITER $1,269 9 payments
  2. GENERAL - PAIN MANAGEMENT $257 4 payments
  3. WAVEWRITER ALPHA $99 1 payment
  4. WaveWriter Alpha Prime 16 $71 2 payments
  5. Zynrelef $69 1 payment
  6. Superion Indirect Decompression System $45 1 payment
  7. LYRICA $43 3 payments
  8. GENERATOR $39 2 payments
  9. STANDARD RF DISPOSABLES $34 1 payment
  10. Omnia $28 1 payment
  11. Other $150 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

668

Median for Pain Management: 951

Drug cost

$8,485

Median for Pain Management: $26,034

Branded share of claims

5.7%

Median for Pain Management: 29.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 203 $2,709
Pregabalin Generic 126 $2,229
Tizanidine Hcl Generic 113 $1,211
Duloxetine Hcl Generic 48 $599
Cyclobenzaprine Hcl Generic 49 $564
Methocarbamol Generic 58 $460
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 24 $369
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 14 $227
Nabumetone Generic 12 $110
Meloxicam Generic 21 $8

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,732 Part D prescribers listed as Pain Management; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$129,990

Medicare's payments for the services billed

Medicare patients

400

Average age 75

Services billed

1,709

252 women, 148 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 30%
Diabetes 29%
Ischemic heart disease 27%
Chronic kidney disease 25%
Osteoporosis 25%
COPD 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

37 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record